|
Market Closed -
Nasdaq
16:00:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 17.74 USD | +5.34% |
|
+0.28% | -41.78% |
| 10-12 | Jefferies & Co Initiates Coverage on Beta Bionics With Buy Rating, $30 Price Target | MT |
| 10-07 | Barclays Initiates Beta Bionics at Overweight With $30 Price Target | MT |
Company Valuation: Beta Bionics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 1,341 | 933.9 | - | - |
| Change | - | -30.38% | - | - |
| Enterprise Value (EV) 1 | 1,130 | 787.1 | 887.6 | 922.9 |
| Change | - | -30.31% | 12.77% | 3.97% |
| P/E | -16.8x | -8.79x | -8.51x | -11.6x |
| PBR | 4.7x | 3.46x | 4.83x | 5.26x |
| PEG | 0.2x | -0.8x | -2.52x | 0.4x |
| Capitalization / Revenue | 13.4x | 7.51x | 5.11x | 3.43x |
| EV / Revenue | 11.3x | 6.33x | 4.86x | 3.39x |
| EV / EBITDA | -21.4x | -11.1x | -11.8x | -23.9x |
| EV / EBIT | -15.8x | -7.71x | -7.89x | -10.3x |
| EV / FCF | -20.1x | -9.24x | -8.27x | -12.6x |
| FCF Yield | -4.98% | -10.8% | -12.1% | -7.96% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -1.81 | -2.017 | -2.085 | -1.529 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 100.3 | 124.4 | 182.6 | 272 |
| EBITDA 1 | -52.75 | -70.94 | -75.51 | -38.61 |
| EBIT 1 | -71.68 | -102.1 | -112.5 | -89.9 |
| Net income 1 | -73.2 | -93.69 | -103.4 | -75.85 |
| Net Debt 1 | -211.9 | -146.7 | -46.25 | -11.01 |
| Reference price 2 | 30.47 | 17.74 | 17.74 | 17.74 |
| Nbr of stocks (in thousands) | 44,025 | 52,642 | - | - |
| Announcement Date | 2/17/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.35x | 5.95x | -10.43x | -.--% | 886M | |
| 33.74x | 5.9x | 22.61x | 0.27% | 251B | |
| 38.19x | 6.77x | 21.42x | 0.64% | 158B | |
| 46.02x | 12.46x | 27.46x | -.--% | 153B | |
| 16.93x | 3.39x | 11.05x | -.--% | 65.29B | |
| 48.5x | 11.99x | 26.42x | -.--% | 51.29B | |
| 20.09x | 2.42x | 12.22x | 2.52% | 51.23B | |
| 35.08x | 6.9x | 21.89x | -.--% | 50.27B | |
| 33.11x | 6.55x | 22.24x | 0.61% | 47.9B | |
| 76.02x | 7.26x | 22.09x | -.--% | 42.67B | |
| Average | 33.93x | 6.96x | 17.70x | 0.4% | 87.15B | |
| Weighted average by Cap. | 37.58x | 7.34x | 21.87x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BBNX Stock
- Valuation Beta Bionics, Inc.
Select your edition
All financial news and data tailored to specific country editions
